A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
Clinical trial NCT07225712 · RECRUITING
Trial details
- NCT number
- NCT07225712
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2028-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.